These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 28929961)

  • 21. Tigecycline antimicrobial activity tested against clinical bacteria from Latin American medical centres: results from SENTRY Antimicrobial Surveillance Program (2011-2014).
    Sader HS; Castanheira M; Farrell DJ; Flamm RK; Mendes RE; Jones RN
    Int J Antimicrob Agents; 2016 Aug; 48(2):144-50. PubMed ID: 27291285
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessment of the Phoenix™ automated system and EUCAST breakpoints for antimicrobial susceptibility testing against isolates expressing clinically relevant resistance mechanisms.
    Giani T; Morosini MI; D'Andrea MM; García-Castillo M; Rossolini GM; Cantón R
    Clin Microbiol Infect; 2012 Nov; 18(11):E452-8. PubMed ID: 22909279
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MALDI-TOF Mass Spectrometry: A Powerful Tool for Clinical Microbiology at Hôpital Principal de Dakar, Senegal (West Africa).
    Lo CI; Fall B; Sambe-Ba B; Diawara S; Gueye MW; Mediannikov O; Sokhna C; Faye N; Diemé Y; Wade B; Raoult D; Fenollar F
    PLoS One; 2015; 10(12):e0145889. PubMed ID: 26716681
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antimicrobial susceptibility among organisms from the Asia/Pacific Rim, Europe and Latin and North America collected as part of TEST and the in vitro activity of tigecycline.
    Reinert RR; Low DE; Rossi F; Zhang X; Wattal C; Dowzicky MJ
    J Antimicrob Chemother; 2007 Nov; 60(5):1018-29. PubMed ID: 17855724
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Susceptibility to tigecycline and linezolid among gram-positive isolates collected in the United States as part of the tigecycline evaluation and surveillance trial (TEST) between 2004 and 2009.
    Dowzicky MJ
    Clin Ther; 2011 Dec; 33(12):1964-73. PubMed ID: 22078154
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Surveillance of bacterial distribution and drug resistance in inpatients with surgical infections: a single center study].
    Jiang KW; Lü Y; Guo P; Ye YJ; Wang H; Wang Q; Zhao CJ; Gao ZD; Cao J; Lü L; Yan YC; Wang S
    Zhonghua Wai Ke Za Zhi; 2013 Jul; 51(7):604-9. PubMed ID: 24256585
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antimicrobial susceptibility and frequency of occurrence of clinical blood isolates in Europe from the SENTRY antimicrobial surveillance program, 1997 and 1998.
    Fluit AC; Jones ME; Schmitz FJ; Acar J; Gupta R; Verhoef J
    Clin Infect Dis; 2000 Mar; 30(3):454-60. PubMed ID: 10722427
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [In vitro susceptibilities to levofloxacin and various antibacterial agents of 12,866 clinical isolates obtained from 72 centers in 2010].
    Yamaguchi K; Ohno A; Ishii Y; Tateda K; Iwata M;
    Jpn J Antibiot; 2012 Jun; 65(3):181-206. PubMed ID: 23173294
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antimicrobial susceptibility profile of selected bacteraemic pathogens from private institutions in South Africa.
    Brink A; Moolman J; da Silva MC; Botha M;
    S Afr Med J; 2007 Apr; 97(4):273-9. PubMed ID: 17446952
    [TBL] [Abstract][Full Text] [Related]  

  • 30. NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007.
    Hidron AI; Edwards JR; Patel J; Horan TC; Sievert DM; Pollock DA; Fridkin SK; ;
    Infect Control Hosp Epidemiol; 2008 Nov; 29(11):996-1011. PubMed ID: 18947320
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Towards a national surveillance program for antimicrobial resistance in animals and animal-derived food.
    Webber J
    Commun Dis Intell Q Rep; 2003; 27 Suppl():S111-6. PubMed ID: 12807285
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CANCER resistance surveillance program: initial results from hematology-oncology centers in North America. Chemotherapy Alliance for Neutropenics and the Control of Emerging Resistance.
    Mutnick AH; Kirby JT; Jones RN;
    Ann Pharmacother; 2003 Jan; 37(1):47-56. PubMed ID: 12503932
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of Clinical Laboratory Standards Institute and European Committee on Antimicrobial Susceptibility Testing guidelines for the interpretation of antibiotic susceptibility at a University teaching hospital in Nairobi, Kenya: a cross-sectional study.
    Kassim A; Omuse G; Premji Z; Revathi G
    Ann Clin Microbiol Antimicrob; 2016 Apr; 15():21. PubMed ID: 27068515
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Antimicrobial resistance of Gram-negative bacilli isolated from 13 teaching hospitals across China].
    Wang Q; Zhao CJ; Wang H; Yu YS; Zhu ZH; Chu YZ; Sun ZY; Hu ZD; Xu XL; Liao K; Xu YC; Zhang LY; Mei YN; Yang B; Ni YX
    Zhonghua Yi Xue Za Zhi; 2013 May; 93(18):1388-96. PubMed ID: 24025503
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Experience of Implementing a National Antimicrobial Resistance Surveillance System in Brazil.
    Pillonetto M; Jordão RTS; Andraus GS; Bergamo R; Rocha FB; Onishi MC; de Almeida BMM; Nogueira KDS; Dal Lin A; Dias VMCH; de Abreu AL
    Front Public Health; 2020; 8():575536. PubMed ID: 33520909
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Monitoring of antimicrobial resistance in pathogenic bacteria from livestock animals.
    Wallmann J
    Int J Med Microbiol; 2006 Jun; 296 Suppl 41():81-6. PubMed ID: 16530479
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evolution of an international external quality assurance model to support laboratory investigation of Streptococcus pneumoniae, developed for the SIREVA project in Latin America, from 1993 to 2005.
    Lovgren M; Talbot JA; Brandileone MC; Casagrande ST; Agudelo CI; Castañeda E; Regueira M; Corso A; Heitmann I; Maldonado A; Echániz-Avilés G; Soto-Noguerón A; Hortal M; Camou T; Gabastou JM; Di Fabio JL;
    J Clin Microbiol; 2007 Oct; 45(10):3184-90. PubMed ID: 17687007
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Harmonization of antimicrobial susceptibility testing among veterinary diagnostic laboratories in the five Nordic countries.
    Petersen A; Aarestrup FM; Hofshagen M; Sipilä H; Franklin A; Gunnarsson E
    Microb Drug Resist; 2003; 9(4):381-8. PubMed ID: 15000745
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A longitudinal analysis of antimicrobial susceptibility in clinical institutions in Germany as part of the Tigecycline Evaluation and Surveillance Trial (2004-2007).
    Seifert H; Dowzicky MJ
    Chemotherapy; 2009; 55(4):241-52. PubMed ID: 19468222
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Antimicrobial susceptibility pattern of nosocomial gram negative pathogens: results from MYSTIC study in Hacettepe University Adult Hospital (2000-2004)].
    Zarakolu P; Hasçelik G; Unal S
    Mikrobiyol Bul; 2006 Jul; 40(3):147-54. PubMed ID: 17001842
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.